The Nature editorial office was peaceful again today.
Dr. Fairchild scratched his head. He couldn't figure out what on earth this person was up to.
“Do American doctors not sleep……. How many papers has this person sent us this year alone? They’re not a paper-writing machine.”
How many times had it happened now? He was sick of it.
“Maybe they are a paper-writing machine.”
No wonder they were the youngest-ever Lasker Award recipient.
Dr. Fairchild looked around.
“We can't reject this one, can we?”
The Nature editor sitting beside Dr. Fairchild merely shrugged.
“Wasn't Stanford where heart transplant surgery was invented? If we reject something like this, people might call us fools who turned down an Einstein-level paper.”
“Hah……. I suppose you're right.”
That was true.
The purpose of a journal's editorial office was to find important papers. They couldn't let a big fish slip through their fingers.
The problem was that one person kept dumping papers that looked like big fish—and couldn't easily be ignored—onto Dr. Fairchild's desk.
-Found the fundamental principle of adaptive immunity!
-Found the Holy Grail of molecular biology! Thanks to a rare bacterium that lives in hot springs!
-Found a new type of pneumonia!
Aaagh.
It was enough to haunt him even in his dreams. He went over the manuscript in question again.
A piece structured more like a book of prophecy than a paper.
Its main point was that cyclosporine, given its lymphocyte-inhibiting properties, could greatly reduce organ rejection.
“Now that I think about it, this is that doctor, right? The one who supposedly worked out in detail how adaptive immunity works.”
“Ah, that one…….”
Dr. Fairchild fell into thought.
That insane paper.
A few years ago, it had sent the Nature editorial office into an uproar. Starting with its absurd structure.
That was how it had been back then.
To a traditional British biologist like Dr. Fairchild, papers written by American doctors like this seemed a little……. insane.
Doctors were like that.
If they thought something might help with treatment, they scribbled it down roughly and rushed to publish. That was considered a virtue.
It was closer to speculation than science.
This person was especially like that.
‘A thought experiment in biology? What are they, Einstein? Doctors…….’
Of course, after carefully reading the Asian doctor's immunology paper, even Dr. Fairchild had no choice but to acknowledge its logic.
That accursed thought experiment.
The logic was simple.
Following that doctor's reasoning, it went like this.
H-2 protein was related to adaptive immunity. Lymphocytes mediated adaptive immunity.
Therefore, H-2 protein must be related to lymphocytes. But there was only one practical way for a cell to convey information to a lymphocyte.
By presenting it directly.
Present what, you ask? Here, too, the simplest answer was written down. Just cut up the molecule targeted by the immune response and present it to the lymphocytes.
That was the content of the accursed paper. What kind of person puts a thought experiment in a medical paper?
This person.
They were out of their mind. Even back then, Dr. Fairchild had been horrified when they read the paper, but it was impossible not to publish it.
The logic was simply too flawless. Like Columbus's egg.
They couldn't go down in medical history as the editor who rejected the first paper to uncover the principles of adaptive immunity…….
This time was no different.
The hypothesis that cyclosporine might be the new key to organ transplantation was extremely appealing. It was something people needed to know about, too.
Dr. Fairchild sighed.
***
I was sitting quietly in the internal medicine residents' room.
I'd finished everything I had to do today.
Besides, a reply had come from Nature saying they'd publish the paper I'd just written. The editorial office did seem to find me rather strange, though.
As I was getting ready to leave work,
Alice shuffled into the residents' room. She looked tired today, but since it was nearly time to go home, perhaps it didn't matter much.
She turned her gaze toward me.
“I heard you got another paper accepted?”
I nodded.
Alice plopped down on the sofa in the residents' room, chewing on a chocolate bar. Sometimes, when she had a quiet shift, she'd sleep there until dawn.
If something happened, someone would come wake her.
Often.
Anyway.
“They accepted it pretty quickly.”
“That's amazing…….”
Alice stared blankly into space.
She was smart and a good doctor who handled patients and children well, but research wasn't really her forte.
She chewed on her chocolate, then rummaged in her pocket and took one out to give me.
“Ah. Thanks.”
“You need sugar to get your brain working.”
Alice chuckled.
Things were going to get busy soon.
It depended on how quickly Professor Shumway could get the hospital moving, but we'd soon start researching a new method of organ transplantation.
I should write that up tomorrow when I got to work.
I should think about a draft proposal for a clinical trial to give Professor Shumway. We hadn't set a deadline, but he'd said we'd try to get it written quickly.
“Let's go home now.”
Alice was standing by the residents' room door with her bag in hand, staging a protest and insisting it was time to go home.
***
Dean Richie pressed his temples.
Professor Shumway was one of the most prominent doctors and researchers at Stanford. His opinion wasn't something they could simply dismiss.
Even if it was a somewhat unreasonable request.
Wasn't he the doctor who invented heart transplant surgery?
Professor Shumway's proposal for a cyclosporine clinical trial was on the dean's desk.
But Dean Richie hadn't missed the strange arrogance in the proposal. This was definitely written by that Asian resident.
A thoracic surgeon—or, no, at the very least, Professor Shumway—wouldn't have written something with such literary phrasing and appeals to emotion.
This was the sort of idea an internist might have.
“You want to start a clinical trial right away?”
“Yes.”
“Why don't we do a little more research first?”
“Isn't that what research is?”
It was an argument with no room for rebuttal.
But.
The dean thought for a moment. In any case, it was true that the evidence still seemed insufficient.
“This is……. It's not easy to move straight to human trials with a drug that's only just completed animal testing. Let's wait a little.”
Professor Shumway shook his head gravely. His expression said they didn't have time.
“Dean. Do you know what the five-year survival rate is for a transplanted kidney?”
“About half, isn't it?”
“That's the patient survival rate. The five-year survival rate of the transplanted organ itself is around 30 percent.”
If a transplanted kidney failed, depending on the case, they might have to remove it in another surgery.
But patients could still survive if they went back on dialysis, so the patient survival rate was higher than the survival rate of the transplanted organ.
One in three.
It was a shocking figure.
“That is low.”
“A child gives a kidney so their parent can live comfortably for a few more years, and even then, only one in three transplanted kidneys lasts five years.”
Professor Shumway sighed.
“Isn't that devastating? Is it even right to tell donors this is what they can expect? Aren't we just giving them another burden to bear?”
“It's not an easy matter.”
Professor Shumway looked at the dean again.
“But. If there's a drug with a new mechanism of action. If it could give a transplanted organ even just one more year…….”
The dean scratched his head.
Professor Shumway was right.
Stanford performed quite a lot of kidney transplants. Even now, patients were coming in to receive kidney transplants.
“Isn't it a little early?”
“There are patients currently hospitalized who are going to receive kidney transplants. If a new treatment could work better right now……. We should start a clinical trial as soon as possible.”
“But. Is the clinical trial for kidney transplants?”
“Yes.”
“Why?”
“Because people have three kidneys.”
Dean Richie frowned for a moment.
Why would anyone have three kidneys?
It took the dean a few seconds to understand the joke. Usually, when a kidney is transplanted, they don't remove the patient's original, damaged kidneys.
Unless something unusual happens, a patient who receives a kidney transplant lives with three kidneys. Though two of them won't function properly.
If you thought about it, it might be a funny joke.
This joke was probably the Asian resident's work, too. Professor Shumway wasn't the sort of person who'd come up with a joke like that.
“I suppose you're right?”
Professor Shumway continued.
“Heart transplants aren't common. And kidney transplants are often between family members, so they might be better subjects for research, given the lower burden of immunosuppression.”
The dean nodded.
“That's the resident's opinion, right?”
“The resident said that since kidney transplants are much more common than heart transplants, it'd be best to apply the clinical trial to kidney transplants first. When you think about it, it's obvious.”
“It really is strange. Where on earth do ideas like that come from…….”
It was a mystery for the ages.
From the dean's perspective, having watched the Asian doctor ever since the moment they first set foot on Stanford's campus, it was even more bizarre.
Professor Shumway cleared his throat briefly.
“So. It'd be best to go ahead with the clinical trial, wouldn't it?”